{
    "clinical_study": {
        "@rank": "117860", 
        "arm_group": [
            {
                "arm_group_label": "G-CSF", 
                "arm_group_type": "Experimental", 
                "description": "Treatment with G-CSF"
            }, 
            {
                "arm_group_label": "Saline", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the effectiveness of treatment with G-CSF in\n      patients with chronic heart failure secondary to Chagas disease."
        }, 
        "brief_title": "A Prospective, Phase II Clinical Trial for Evaluation of G- CSF (Colony Stimulating Factor) in Patients With Chronic Chagas Cardiomyopathy", 
        "condition": "Chronic Chagasic Myocarditis", 
        "condition_browse": {
            "mesh_term": [
                "Chagas Cardiomyopathy", 
                "Myocarditis", 
                "Cardiomyopathies"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of Chagas' disease confirmed by two serological tests with different\n             methodologies;\n\n          -  Diagnosis of Chagas' cardiomyopathy in NYHA functional classes II, III and IV of\n             heart failure;\n\n          -  Availability and willingness to participate, given the schedule of the study;\n\n          -  Agreement and signing the written form.\n\n        Exclusion Criteria:\n\n          -  Acute systemic infections\n\n          -  Solid neoplasms, myelodysplastic syndrome, acute or chronic myeloid leukemia,\n             confirmed by imaging studies or past medical history;\n\n          -  Valvulopathies with hemodynamic consequences;\n\n          -  Autoimmune, pulmonary, or degenerative diseases, confirmed by imaging studies or past\n             medical history;\n\n          -  Severe renal, hepatic or thyroid dysfunction, confirmed by imaging studies or past\n             medical history;\n\n          -  Pregnancy (confirmed by examination of \u03b2 HCG) or lactation;\n\n          -  Known hypersensitivity to G-CSF or to other components of the formula and / or\n             hypersensitivity to proteins derived from E. coli."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 30, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02154269", 
            "org_study_id": "PCL07/12"
        }, 
        "intervention": [
            {
                "arm_group_label": "G-CSF", 
                "intervention_name": "Treatment with G-CSF (Granulocyte colony stimulating factor)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Saline", 
                "intervention_name": "Placebo saline", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Lenograstim"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Chagas disease", 
            "G-CSF", 
            "Cell therapy"
        ], 
        "lastchanged_date": "June 2, 2014", 
        "location": {
            "contact": {
                "email": "milenabpsoares@gmail.com", 
                "last_name": "Milena BP Soares, PhD", 
                "phone": "557132816489"
            }, 
            "facility": {
                "address": {
                    "city": "Salvador", 
                    "country": "Brazil", 
                    "state": "Bahia", 
                    "zip": "41253-190"
                }, 
                "name": "Hospital S\u00e3o Rafael"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prospective, Double-blind, Randomized, Placebo-controlled Phase II Clinical Trial for Evaluation of G-CSF in Patients With Chronic Chagas Cardiomyopathy", 
        "overall_contact": {
            "email": "milenabpsoares@gmail.com", 
            "last_name": "Milena BP Soares, PhD", 
            "phone": "557132816489"
        }, 
        "overall_official": [
            {
                "affiliation": "Hospital S\u00e3o Rafael", 
                "last_name": "Milena BP Soares, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital S\u00e3o Rafael", 
                "last_name": "Ticiana F Larocca, MD, Msc", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Hospital S\u00e3o Rafael", 
                "last_name": "Ricardo Ribeiro-dos-Santos, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Hospital S\u00e3o Rafael", 
                "last_name": "Bruno SF Souza, MD, Msc", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Hospital S\u00e3o Rafael", 
                "last_name": "M\u00e1rcia MN Rabelo, MD, Msc", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Hospital S\u00e3o Rafael", 
                "last_name": "Lu\u00eds Cl\u00e1udio L Correia, MD, Msc", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Hospital S\u00e3o Rafael", 
                "last_name": "Carolina T Macedo, MD, Msc", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Brazil: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "All patients will undergo periodic clinical evaluations in order to identify improvement on NYHA classification for heart failure.", 
            "measure": "NYHA (New York Heart Association) functional class improvement", 
            "safety_issue": "No", 
            "time_frame": "6, 9 and 12 months after the therapy with G-CSF"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02154269"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hospital Sao Rafael", 
            "investigator_full_name": "Milena Botelho Pereira Soares", 
            "investigator_title": "PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "All patients will be submitted to echocardiography after 6 and 12 months to assess improvements on ventricular function.", 
                "measure": "Assessment of cardiovascular function measured by transthoracic echocardiography", 
                "safety_issue": "No", 
                "time_frame": "6 and 12 months after the therapy"
            }, 
            {
                "description": "All patients will be submitted to a second cardiac magnetic resonance, after 12 months, to assess improvements on left ventricular ejection fraction.", 
                "measure": "Assessment of cardiovascular function measured by cardiac magnetic resonance imaging", 
                "safety_issue": "No", 
                "time_frame": "12 months after therapy"
            }, 
            {
                "description": "All patients will be submitted to a second treadmill test and 6-minute walk test after 12 months to assess improvement on functional capacity.", 
                "measure": "Evaluation of functional capacity assessed by treadmill test and by 6-minute walk test", 
                "safety_issue": "No", 
                "time_frame": "12 months after the therapy"
            }, 
            {
                "description": "All patients will respond to Minnesota Questionnaire to have an evaluation of quality of life after 6 and 12 months.", 
                "measure": "Evaluation of improvement of quality of life", 
                "safety_issue": "No", 
                "time_frame": "6 and 12 months after the therapy"
            }, 
            {
                "description": "All patients will be submitted to complete blood counts in several time frames in order to evaluate tolerability to G-CSF injection.", 
                "measure": "Determination of tolerability", 
                "safety_issue": "Yes", 
                "time_frame": "1, 5, 13, 17, 25, 29, 37 and 41 days and 3, 6, 9 and 12 months after the therapy"
            }
        ], 
        "source": "Hospital Sao Rafael", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospital Sao Rafael", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}